StockData
Telomir Pharmaceuticals, Inc. logo

Telomir Pharmaceuticals, Inc. (TELO) dividend history

TELONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$0.49−0.01 (-1.96%)

Close on Nov 13, 2026Market cap $33.74MP/E –Yield –

Dividends

Telomir Pharmaceuticals has not reported a dividend

No dividend per share appears in Telomir Pharmaceuticals's annual filings since fiscal 2021.

See a number that looks wrong?